EDP Sciences logo
Rechercher
Menu
Tous les numéros Volume 25 / Numéro 1 (2013) Ann Toxicol Anal, 25 1 (2013) 1-5 Références
Open Access
Numéro
Ann Toxicol Anal
Volume 25, Numéro 1, 2013
Page(s) 1 - 5
DOI https://doi.org/10.1051/ata/2013029
Publié en ligne 13 juin 2013
  1. United Nations Office on Drugs and Crime, World Drug Report 2006. [Google Scholar]
  2. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), The State of the Drugs Problem in Europe, Annual Report 2011. [Google Scholar]
  3. Huestis MA. Cannabis (Marijuana)-effects on human behaviour and performance. Forensic Sci Rev. 2002; 14(1-2): 16–60. [Google Scholar]
  4. Hall W, Degenhardt L. Adverse health effects of nonmedical cannabis use. Lancet. 2009; 374(9698): 1383–1391. [CrossRef] [PubMed] [Google Scholar]
  5. Schwope DM, Scheidweiler KB, Huestis MA. Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography–tandem mass spectrometry. Anal Bioanal Chem. 2011; 401(4): 1273–1283. [CrossRef] [PubMed] [Google Scholar]
  6. Seely KA, Prather PL, James LP, Moran JH. Marijuana based drugs: innovative therapeutics or designer drugs of abuse?. Mol Interv. 2011; 11(1): 36–51. [CrossRef] [PubMed] [Google Scholar]
  7. Leussink VI, Husseini L, Warnke C, Broussalis E, Hartung HP, Kieseier BC. Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity. Ther Adv Neurol Disord. 2012; 5(5): 255–266. [CrossRef] [PubMed] [Google Scholar]
  8. Watanabe K, Yamaori S, Funahashi T, Kimura T, Yamamoto I. Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes. Life Sci. 2007; 80(15): 1415–1419. [CrossRef] [PubMed] [Google Scholar]
  9. Watanabe K, Matsunaga T, Yamamoto I, Funae Y, Yoshimura H. Involvement of CYP2C in the metabolism of cannabinoids by human hepatic microsomes from an old woman. Biol Pharm Bull. 1995; 18:1138–1141. [CrossRef] [PubMed] [Google Scholar]
  10. Richardson TH, Jung F, Griffin KJ, Wester M, Raucy JL, Kemper B, Bornheim LM, Hassett C, Omiecinski CJ, Johnson EF. A universal approach to the expression of human and rabbit cytochrome P450s of the 2C subfamily in Escherichia coli. Arch Biochem Biophys. 1995; 323(1): 87–96. [CrossRef] [PubMed] [Google Scholar]
  11. Bäckström B, Cole MD, Carrott MJ, Jones DC, Davidson G, Coleman K. A preliminary study of the analysis of cannabis by supercritical fluid chromatography with atmospheric pressure chemical ionisation mass spectroscopic detection. Sci Justice. 1997; 37(2): 91–97. [CrossRef] [PubMed] [Google Scholar]
  12. Elian AA, Hackett J. Solid-phase extraction and analysis of THC and carboxy-THC from whole blood using a novel fluorinated solid-phase extraction sorbent and fast liquid chromatography–tandem mass spectrometry. J Anal Toxicol. 2009; 33(8): 461–468. [CrossRef] [PubMed] [Google Scholar]
  13. Del Mar Ramirez Fernandez M, De Boeck G,Wood M, Lopez-Rivadulla M, Samyn N. Simultaneous analysis of THC and its metabolites in blood using liquid chromatography–tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2008; 875(2): 465–470. [CrossRef] [PubMed] [Google Scholar]
  14. Valiveti S, Hammell DC, Earles DC, Stinchcomb AL. LC–MS method for the estimation of delta8-THC and 11-nor-delta8-THC-9-COOH in plasma. J Pharm Biomed Anal. 2005; 38(1): 112–118. [CrossRef] [PubMed] [Google Scholar]
  15. de Jager AD, Bailey NL. Online extraction LC-MS/MS method for the simultaneous quantitative confirmation of urine drugs of abuse and metabolites: amphetamines, opiates, cocaine, cannabis, benzodiazepines and methadone. J Chromatogr B Analyt Technol Biomed Life Sci. 2011; 879(25): 2642–2652. [CrossRef] [PubMed] [Google Scholar]
  16. Grauwiler SB, Scholer A, Drewe J. Development of a LC/MS/MS method for the analysis of cannabinoids in human EDTA plasma and urine after small doses of Cannabis sativa extracts. J Chromatogr B Analyt Technol Biomed Life Sci. 2007; 850(1-2): 515–522. [CrossRef] [PubMed] [Google Scholar]
  17. Ferreirós N, Labocha S, Walter C, Lötsch J, Geisslinger G. Simultaneous and sensitive LC–MS/MS determination of tetrahydrocannabinol and metabolites in human plasma. Anal Bioanal Chem. 2013; 405(4): 1399–1406. [CrossRef] [PubMed] [Google Scholar]
  18. König S, Aebi B, Lanz S, Gasser M, Weinmann W. On-line SPE LC-MS/MS for the quantification of Delta9-tetrahydrocannabinol (THC) and its two major metabolites in human peripheral blood by liquid chromatography tandem mass spectrometry. Anal Bioanal Chem. 2011; 400(1): 9–16. [CrossRef] [PubMed] [Google Scholar]
  19. Groupe de travail «Accréditation» de la Société Française de Toxicologie Analytique. Aide à la validation des méthodes en toxicologie et suivi thérapeutique pharmacologique. Annal Toxicol Anal. 2005; 17(3) suppl: 1–20. [Google Scholar]
  20. Sadeg N, Bouchene S, Frances B, Coulais Y, Tafani M, Palmaro A, Deprez D, Belhadj-Tahar H. Toxicovigilance of cannabinomimetic drugs: pertinence and contribution of predictive toxicology, IVth Mediterranean Academy Of Forensic Sciences Meeting, Antalya 2009. [Google Scholar]